Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

Molecular Brain Research

Volumn 36, Issue 1, 1996, Pages 157-162

  Harrington, K A ^a   Augood, S J ^a   Kingsbury, A E ^b   Foster, O J F ^b   Emson, P C ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b Institute of Neurology   (United Kingdom)

Author keywords

Dopamine transporter; In situ hybridization; Neuromelanin; Parkinson's disease; Synaptic vesicle amine transporter

Indexed keywords

AMINE; CARRIER PROTEIN; DOPAMINE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE;

AGED; AMINE TRANSPORT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SYNAPSE VESICLE;

PARKINSONIA;

EID: 0030026109     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00278-Z     Document Type: Article

References (29)

1. Allard, P.O., Rinne, J. and Marcusson, J.O., Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type, Brain Res., 637 (1994) 262-266.
2. 67-immunoreactivity and parvalbumin mRNA, J. Neurosci., 15 (1995) 865-874.
3. Augood, S.J., Westmore, K., McKenna, P.J. and Emson, P.C., Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones, Mol. Brain Res., 20 (1993) 328-334.
4. Axelrod, J., The metabolism, storage and release of catecholamines, Recent Prog. Horm. Res., 21 (1965) 597-619.
5. 3H-spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy, Eur. J. Pharmacol., 99 (1984) 167-175.
6. Burns, R.S., Chiuech, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M. and Kopin, I.J., A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Natl. Acad. Sci., USA 80 (1983) 4546-4550.
7. Cohen, G., The pathophysiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence, J. Neural Transm., Suppl. 19 (1983) 89-103.
8. Cohen, G., Monoamine oxidase and oxidative stress at dopaminergic synapses, J. Neural Transm., Suppl. 32 (1990) 229-238.
9. 28k-containing cells, Ann. NY Acad. Sci., 648 (1992) 42-62.
10. Giros, B., El Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T. and Caron, M.G., Cloning, pharmacological characterisation, and chromosome assignment of the human dopamine transporter, Mol. Pharmacol., 42 (1992) 383-390.
11. Herrero, M.T., Hirsch, E.C., Kastner, A., Ruberg, M., Luquin, M.R., Laguna, J., Javoy-Agid, F., Obeso, J.A. and Agid, Y., Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP, Neuroscience, 56 (1993) 499-511.
12. Hirsch, E., Graybiel, A.M. and Agid, Y.A., Melanised dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease, Nature, 334 (1988) 345-348.
13. Horn, A.S., Dopamine uptake: a review of progress in the last decade, Prog. Neurobiol., 34 (1990) 387-400.
14. Hornykiewicz, O., Dopamine (3-hydroxytyramine) and brain function, Pharmac. Rev., 18 (1966) 925-964.
15. Jellinger, K., Pathology of parkinsonism. In: S. Fahn, C.D. Marsden, P. Jenner and P. Teychenne (Eds.), Recent Developments in Parkinson's Disease, Raven Press, New York, 1986, pp. 33-66.
16. Javitch, J.A., D'Amato, R.T., Strittmatter, S.M. and Snyder, D., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. USA, 82 (1985) 2173-2177.
17. Javoy-Agid, F., Hirsch, E.G., Dumas, S., Duyckaerts, C., Mallet, J. and Agid, Y., Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridisation study, Neuroscience, 38 (1990) 245-253.
18. Kastner, A., Hirsch, E.C., Agid, Y. and Javoy-Agid, F., Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurones of patients with Pakinson's disease, Brain Res., 606 (1993) 341-345.
19. Kingsbury, A.E., Foster, O.J. F., Nisbet, A.P., Cairns, N., Bray, L., Eve, D.J., Lees, A.J. and Marsden, C.D., Tissue pH as an indicator of mRNA preservation in human post-mortem brain, Mol. Brain Res., 28 (1995) 311-318.
20. Lehericy, S., Brandel, J.-P., Hirch, B.C., Anglade, P., Villares, J., Scherman, D., Duyckaerts, C., Javoy-Agid, F. and Agid, Y., Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by titrated dihydrotetrabenzine autoradiography, Brain Res., 659 (1994) 1-9.
21. + toxicity, Mol. Brain Res., 25 (1994) 90-96.
22. + toxicity encodes a vesicular amine transporter, Cell, 70 (1992) 539-551.
23. McGeer, P.L., Itagaki, Q., Akiyama, H. and McGeer, E.G., Rate of cell death in Parkinsonism indicates an active neuropathological process, Ann. Neurol., 24 (1988) 574-576.
24. McGeer, P.L., McGeer, E.G. and Suzuki, J.S., Ageing and extrapyramidal function, Arch. Neurol., 34 (1977) 33-35.
25. Riederer, P. and Wuketich, S., Time course of nigrostriatal degeneration in Parkinson's disease, J. Neural Transm., 38 (1976) 277-301.
26. Reinhard, J.F. Jr., Diliberto, E.J. Jr., Viveros, O.H. and Daniels, A.J., Subcellular compartmentalization of 1-methyl-4-phenyl-pyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells, Proc. Natl. Acad. Sci. USA, 84 (1987) 8160-8164.
27. Schapira, A.H.V., Mam, V.N., Cooper, J.M., Krige, D., Jenner, P.J. and Marsden, C.D., Mitochondrial function in Parkinson's disease, Ann. Neurol., 32 (1992) S116-S124.
28. Schultz, W., MPTP-induced parkinsonism in monkeys: mechanism of action, selectivity and pathophysiology, Gen. Pharmacol., 19 (1988) 153-161.
29. Uhl, G.R., Walther, D., Mash, D., Faucheux, B. and Javoy-Agid, F., Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurones, Ann. Neurol., 35 (1994) 494-498.